An ISO 13485 quality management system (QMS) specifies requirements for the design and manufacture of medical devices. In vitro diagnostic (IVD) devices must meet customer and regulatory requirements within this framework. For manufacturers seeking to ensure the quality and safety of their products, understanding ISO 13485 is essential.
According to ISO 13485, a qualified quality management system demonstrates the ability to provide medical devices and related services that consistently meet regulatory and customer requirements. From design and development to production, installation, and service, it encompasses all aspects of medical device production.
ISO 13485 is an international standard, not a law. It is published by the International Organization for Standardization, and the current edition is ISO 13485:2016. On its own, adopting the standard is voluntary. It becomes binding when a regulator references it, which is why manufacturers treat it as a practical requirement rather than an optional exercise.
In Saudi Arabia this distinction matters. A quality management system that meets the standard is what allows an organisation to evidence control over its processes when the Saudi Food and Drug Authority reviews an application or inspects a site.
ISO 13485 is organised into eight clauses. The first three cover scope, normative references, and terms and definitions. The auditable requirements sit in clauses 4 to 8:
The standard is written for any organisation involved in one or more stages of the medical device lifecycle. That includes device and in vitro diagnostic manufacturers, and also organisations providing associated services such as storage, distribution, installation, and servicing.
In the Saudi market this reaches beyond the manufacturer. SFDA requirements approach this from two directions. A manufacturer applying for marketing authorization shall establish, document and maintain an effective quality management system according to ISO 13485:2016 or an identical adopted standard. Establishment licensing then requires manufacturers, importers and distributors to meet the quality management system requirements of the adopted Saudi standard SFDA.MD/GSO ISO 13485:2017 or its equivalent, and establishments in categories (A) and (B) must hold a certificate of conformity issued by a conformity assessment body accredited by the SFDA. If you are applying for a Medical Device Establishment License (MDEL), the quality system is part of what you are assessed on.
For companies entering the Saudi market, ISO 13485 is where regulatory expectation and day to day operations meet. For a manufacturer seeking marketing authorization, a compliant quality management system is not optional: SFDA requirements state that the manufacturer shall establish, document and maintain an effective quality management system according to ISO 13485:2016 or an identical adopted standard.
A well designed system does more than satisfy an assessor. It reduces product risk, supports your application for Medical Device Marketing Authorization (MDMA), and underpins the post-market surveillance obligations that continue once the device is on the market. Alignment with ISO 14971 risk management and relevant GHTF and IMDRF guidance keeps the system coherent across markets rather than built for one regulator alone.
The quality system and the device dossier are closely connected. Design and development controls under clause 7 generate much of the evidence that later appears in a submission, and clause 4 governs how that evidence is documented and retained.
For manufacturers preparing to enter Saudi Arabia, this means the quality system should produce technical documentation as a by-product of normal operations rather than as a separate exercise at submission time. Our technical file preparation service covers how that evidence is assembled into an SFDA ready dossier.
Clause 4 sets the documentation framework: the quality manual, the medical device file, and control of documents and records. The procedures an assessor most often asks to see sit further into the standard. Traceability is clause 7.5.9, preservation of product, which covers storage and transport conditions, is clause 7.5.11, complaint handling is clause 8.2.2, and reporting to regulatory authorities is clause 8.2.3.
These are the procedures an authority typically asks to see, along with the records proving they are followed. We cover each one in detail in our guide to the core ISO 13485 requirements every medical company must follow.
Medical device manufacturers can improve their medical devices safety and efficacy through ISO 13485 compliance by:
In ISO 13485, audit reports provide a systematic review of the QMS to ensure compliance with the standard. The purpose of these reports is to:
Maintaining high standards is demonstrated through regular audits and transparent reporting, which builds trust with stakeholders, including customers and regulatory authorities.
An ISO 13485 audit examines whether the quality management system described on paper is the system actually being operated. Preparation is therefore less about producing documents for the auditor and more about confirming that records, procedures, and practice agree with one another.
ISO does not certify organisations. Certification is issued by independent certification bodies that audit the quality management system against the standard. Broadly, an organisation implements the system, runs internal audits and a management review, then undergoes an external audit before a certificate is issued, with surveillance audits following to maintain it.
In Saudi Arabia the relevant point is not certification in the abstract but whether the body issuing your certificate is accredited by the SFDA, since establishments in categories (A) and (B) must obtain their certificate of conformity from an SFDA accredited conformity assessment body. Confirm that recognition before engaging a certification body.
In vitro diagnostic devices fall within the same quality management framework, and the standard expects the system to reflect the nature of the product. For IVDs that means design and development controls, and the measurement and analysis requirements of clause 8, carry particular weight because performance claims rest on analytical and clinical evidence.
Our performance evaluation service for IVDs addresses how that evidence is generated and presented, and our article on accuracy and precision in IVD devices explains why these measures matter for safety.
ISO 13485 is a stand-alone standard, though it was based on ISO 9001:2008. Its full title, Medical devices, Quality management systems, Requirements for regulatory purposes, points to the difference: it is written to be used for regulatory purposes and carries medical device specific requirements that a general quality management standard does not, among them the medical device file, traceability, and reporting to regulatory authorities.
Lastly,
The ISO 13485 standard is a cornerstone of the medical device industry, providing a comprehensive framework for ensuring quality and safety. Manufacturers can achieve regulatory compliance, improve product quality, and ensure patient safety by implementing and maintaining a QMS that meets ISO 13485 requirements. This process relies heavily on audit reports to identify non-conformities, drive continuous improvement, and provide regulatory evidence. ISO 13485 is recognized as an essential standard by regulatory bodies, including the Saudi FDA.
Bio-Standards helps medical device and IVD manufacturers build and maintain ISO 13485 quality systems aligned with SFDA expectations. Explore our quality management system solutions or talk to our regulatory team.
.svg)
